Startseite Measurement of plasma vitamin K1 (phylloquinone) and K2 (menaquinones-4 and -7) using HPLC-tandem mass spectrometry
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Measurement of plasma vitamin K1 (phylloquinone) and K2 (menaquinones-4 and -7) using HPLC-tandem mass spectrometry

  • Ineke J. Riphagen ORCID logo EMAIL logo , Jan C. van der Molen , Martijn van Faassen , Gerjan Navis , Martin H. de Borst , Frits A.J. Muskiet , Wilhelmina H.A. de Jong , Stephan J.L. Bakker und Ido P. Kema
Veröffentlicht/Copyright: 2. Dezember 2015
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Given the growing interest in the health benefits of vitamin K, there is great need for development of new high-throughput methods for quantitative determination of vitamin K in plasma. We describe a simple and rapid method for measurement of plasma vitamin K1 (phylloquinone [PK]) and K2 (menaquinones [MK]-4 and -7). Furthermore, we investigated the association of fasting plasma vitamin K with functional vitamin K insufficiency in renal transplant recipients (RTR).

Methods: We used HPLC-tandem mass spectrometry with atmospheric pressure chemical ionization for measurement of plasma PK, MK-4, and MK-7. Solid-phase extraction was used for sample clean-up. Mass spectrometric detection was performed in multiple reaction monitoring mode. Functional vitamin K insufficiency was defined as plasma desphospho-uncarboxylated matrix Gla protein (dp-ucMGP) >500 pmol/L.

Results: Lower limits of quantitation were 0.14 nmol/L for PK and MK-4 and 4.40 nmol/L for MK-7. Linearity up to 15 nmol/L was excellent. Mean recoveries were >92%. Fasting plasma PK concentration was associated with recent PK intake (ρ=0.41, p=0.002) and with plasma MK-4 (ρ=0.49, p<0.001). Plasma PK (ρ=0.38, p=0.003) and MK-4 (ρ=0.46, p<0.001) were strongly correlated with plasma triglyceride concentrations. Furthermore, we found that MK-4-triglyceride ratio, but not PK-triglyceride ratio, was significantly associated with functional vitamin K insufficiency (OR 0.22 [0.07–0.70], p=0.01) in RTR.

Conclusions: The developed rapid and easy-to-use LC-MS/MS method for quantitative determination of PK, MK-4, and MK-7 in human plasma may be a good alternative for the labor-intensive and time-consuming LC-MS/MS methods and enables a higher sample throughput.


Corresponding author: Ineke J. Riphagen, Division of Nephrology Department of Internal Medicine, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands, Phone: +31 50 361 6161; Fax: +31 50 361 9310, E-mail: . http://orcid.org/0000-0001-5500-0145; Top Institute Food and Nutrition, Wageningen, The Netherlands; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

References

1. Beulens JW, Booth SL, van den Heuvel EG, Stoecklin E, Baka A, Vermeer C. The role of menaquinones (vitamin K(2)) in human health. Br J Nutr 2013;110:1357–68.10.1017/S0007114513001013Suche in Google Scholar

2. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:1256–61.10.1001/archinte.166.12.1256Suche in Google Scholar

3. Fusaro M, Noale M, Viola V, Galli F, Tripepi G, Vajente N, et al. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012;27:2271–8.10.1002/jbmr.1677Suche in Google Scholar

4. Beulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009;203:489–3.10.1016/j.atherosclerosis.2008.07.010Suche in Google Scholar

5. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the rotterdam study. J Nutr 2004;134:3100–5.10.1093/jn/134.11.3100Suche in Google Scholar

6. Shearer MJ. Vitamin K metabolism and nutriture. Blood Rev 1992;6:92–104.10.1016/0268-960X(92)90011-ESuche in Google Scholar

7. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr 1998;128:785–8.10.1093/jn/128.5.785Suche in Google Scholar PubMed

8. Ducros V, Pollicand M, Laporte F, Favier A. Quantitative determination of plasma vitamin K1 by high-performance liquid chromatography coupled to isotope dilution tandem mass spectrometry. Anal Biochem 2010;401:7–14.10.1016/j.ab.2010.02.018Suche in Google Scholar PubMed

9. Booth SL, Tucker KL, McKeown NM, Davidson KW, Dallal GE, Sadowski JA. Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J Nutr 1997;127:587–92.10.1093/jn/127.4.587Suche in Google Scholar PubMed

10. McKeown NM, Jacques PF, Gundberg CM, Peterson JW, Tucker KL, Kiel DP, et al. Dietary and nondietary determinants of vitamin K biochemical measures in men and women. J Nutr 2002;132:1329–34.10.1093/jn/132.6.1329Suche in Google Scholar PubMed

11. Azharuddin MK, O’Reilly DS, Gray A, Talwar D. HPLC method for plasma vitamin K1: effect of plasma triglyceride and acute-phase response on circulating concentrations. Clin Chem 2007;53:1706–13.10.1373/clinchem.2007.086280Suche in Google Scholar PubMed

12. Moussa F, Dufour L, Didry JR, Aymard P. Determination of trans-phylloquinone in children’s serum. Clin Chem 1989;35:874–8.10.1093/clinchem/35.5.874Suche in Google Scholar

13. Paroni R, Faioni EM, Razzari C, Fontana G, Cattaneo M. Determination of vitamin K1 in plasma by solid phase extraction and HPLC with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:351–4.10.1016/j.jchromb.2008.12.044Suche in Google Scholar PubMed

14. Kamao M, Suhara Y, Tsugawa N, Okano T. Determination of plasma Vitamin K by high-performance liquid chromatography with fluorescence detection using Vitamin K analogs as internal standards. J Chromatogr B Analyt Technol Biomed Life Sci 2005;816:41–8.10.1016/j.jchromb.2004.11.003Suche in Google Scholar PubMed

15. Suhara Y, Kamao M, Tsugawa N, Okano T. Method for the determination of vitamin K homologues in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem 2005;77:757–63.10.1021/ac0489667Suche in Google Scholar PubMed

16. Gentili A, Cafolla A, Gasperi T, Bellante S, Caretti F, Curini R, et al. Rapid, high performance method for the determination of vitamin K(1), menaquinone-4 and vitamin K(1) 2,3-epoxide in human serum and plasma using liquid chromatography-hybrid quadrupole linear ion trap mass spectrometry. J Chromatogr A 2014;1338:102–110.10.1016/j.chroma.2014.02.065Suche in Google Scholar PubMed

17. Boxma PY, van den Berg E, Geleijnse JM, Laverman GD, Schurgers LJ, Vermeer C, et al. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients. PLoS One 2012;7:e47991.10.1371/journal.pone.0047991Suche in Google Scholar PubMed PubMed Central

18. Keyzer CA, Vermeer C, Joosten MM, Knapen MH, Drummen NE, Navis G, et al. Vitamin K status and mortality after kidney transplantation: a cohort study. Am J Kidney Dis 2015;65: 474–83.10.1053/j.ajkd.2014.09.014Suche in Google Scholar PubMed

19. The Hague: Dutch food composition table (NEVO 2006) NEVO tabel 2006 (Dutch nutrient databank: NEVO table 2006): Voorlichtingsbureau voor de voeding.Suche in Google Scholar

20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.10.7326/0003-4819-150-9-200905050-00006Suche in Google Scholar PubMed PubMed Central

21. Cranenburg EC, Koos R, Schurgers LJ, Magdeleyns EJ, Schoonbrood TH, Landewe RB, et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010;104:811–22.10.1160/TH09-11-0786Suche in Google Scholar PubMed

22. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65(Suppl 4):1220S–8S; discussion 1229S–1231S.10.1093/ajcn/65.4.1220SSuche in Google Scholar

23. National Academy of Sciences, Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for vitamin A, vitamin K, arseni, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, D.C., USA: National Academy Press, 2001.Suche in Google Scholar

24. Fusaro M, Crepaldi G, Maggi S, Galli F, D’Angelo A, Calo L, et al. Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship. J Endocrinol Invest 2011;34:317–23.10.1007/BF03347093Suche in Google Scholar

25. Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 2008;5:e196.10.1371/journal.pmed.0050196Suche in Google Scholar

26. Al Rajabi A, Booth SL, Peterson JW, Choi SW, Suttie JW, Shea MK, et al. Deuterium-labeled phylloquinone has tissue-specific conversion to menaquinone-4 among Fischer 344 male rats. J Nutr 2012;142:841–5.10.3945/jn.111.155804Suche in Google Scholar

27. Sadowski JA, Hood SJ, Dallal GE, Garry PJ. Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. Am J Clin Nutr 1989;50:100–8.10.1093/ajcn/50.1.100Suche in Google Scholar

28. Cham BE, Smith JL, Colquhoun DM. Interdependence of serum concentrations of vitamin K1, vitamin E, lipids, apolipoprotein A1, and apolipoprotein B: importance in assessing vitamin status. Clin Chim Acta 1999;287:45–57.10.1016/S0009-8981(99)00117-5Suche in Google Scholar

29. Lamon-Fava S, Sadowski JA, Davidson KW, O’Brien ME, McNamara JR, Schaefer EJ. Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am J Clin Nutr 1998;67:1226–31.10.1093/ajcn/67.6.1226Suche in Google Scholar PubMed

Received: 2015-9-4
Accepted: 2015-10-24
Published Online: 2015-12-2
Published in Print: 2016-7-1

©2016 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. In Memoriam: Gérard Siest (1936–2016)
  3. Editorials
  4. Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine
  5. The quality indicator paradox
  6. Review
  7. Clinical utility of the (-2)proPSA and evaluation of the evidence: a systematic review
  8. Mini Review
  9. Why are clinical practice guidelines not followed?
  10. EFLM Position Paper
  11. Patient identification and tube labelling – a call for harmonisation
  12. Genetics and Molecular Diagnostics
  13. A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function
  14. Performance of two commercially available BCR-ABL1 quantification assays that use an international reporting scale
  15. HAND1 loss-of-function mutation associated with familial dilated cardiomyopathy
  16. General Clinical Chemistry and Laboratory Medicine
  17. Performance criteria and quality indicators for the post-analytical phase
  18. Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
  19. Quantitative determination of four immunosuppressants by high resolution mass spectrometry (HRMS)
  20. Measurement of plasma vitamin K1 (phylloquinone) and K2 (menaquinones-4 and -7) using HPLC-tandem mass spectrometry
  21. Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits
  22. High level of oxysterols in neonatal cholestasis: a pitfall in analysis of biochemical markers for Niemann-Pick type C disease
  23. Reference Values and Biological Variations
  24. Reference intervals of plasma homoarginine from the German Gutenberg Health Study
  25. TSH and fT4 during pregnancy: an observational study and a review of the literature
  26. Cancer Diagnostics
  27. Mean corpuscular volume levels and all-cause and liver cancer mortality
  28. Cardiovascular Diseases
  29. Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure
  30. Hematology and Coagulation
  31. Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medication
  32. Letters to the Editor
  33. EQA-derived metrics to assess overall instrument performance
  34. Misidentification in laboratory medicine and diagnostic process: a neglected problem calling for action
  35. Impact of the routine implementation of automated indirect immunofluorescence antinuclear antibody analysis: 1 year of experience
  36. The importance of angiogenic markers in the differential diagnosis of HELLP syndrome vs. non-HELLP thrombocytopenia
  37. Bisalbuminemia accompanying bisalbuminuria detected in capillary electrophoresis, not in gel electrophoresis
  38. Prognostic value of red blood cell distribution width in acute pancreatitis patients admitted to intensive care units: an analysis of a publicly accessible clinical database MIMIC II
  39. Differences in analytical and biological results between older and newer lots of a widely used irisin immunoassay question the validity of previous studies
  40. A diagnostic algorithm for the detection of inhibitors against coagulation Factor V
  41. Interference of anticoagulants on coagulation testing
  42. Congress Abstracts
  43. Swiss MedLab 2016 and 74th Annual Meeting of the Swiss Society of Microbiology SSM, Bern, 13–16 June 2016
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0864/pdf
Button zum nach oben scrollen